25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Mankind Pharma Ltd
Buy, Hold or Sell?

Let's analyze Mankind Pharma Ltd together

I guess you are interested in Mankind Pharma Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Mankind Pharma Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Mankind Pharma Ltd

I send you an email if I find something interesting about Mankind Pharma Ltd.

1. Quick Overview

1.1. Quick analysis of Mankind Pharma Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Mankind Pharma Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
33.3%

What is your share worth?

Current worth
INR238.68
Expected worth in 1 year
INR429.74
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR191.06
Return On Investment
7.5%

For what price can you sell your share?

Current Price per Share
INR2,551.60
Expected price per share
INR2,378 - INR2,874
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Mankind Pharma Ltd (5 min.)




Live pricePrice per Share (EOD)
INR2,551.60
Intrinsic Value Per Share
INR349.57 - INR477.78
Total Value Per Share
INR588.25 - INR716.45

2.2. Growth of Mankind Pharma Ltd (5 min.)




Is Mankind Pharma Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$902.5m$227.3m20.1%

How much money is Mankind Pharma Ltd making?

Current yearPrevious yearGrowGrow %
Making money$225.7m$151.2m$74.4m33.0%
Net Profit Margin18.5%14.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Mankind Pharma Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Mankind Pharma Ltd?

Welcome investor! Mankind Pharma Ltd's management wants to use your money to grow the business. In return you get a share of Mankind Pharma Ltd.

First you should know what it really means to hold a share of Mankind Pharma Ltd. And how you can make/lose money.

Speculation

The Price per Share of Mankind Pharma Ltd is INR2,552. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mankind Pharma Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mankind Pharma Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR238.68. Based on the TTM, the Book Value Change Per Share is INR47.76 per quarter. Based on the YOY, the Book Value Change Per Share is INR33.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mankind Pharma Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.560.0%0.560.0%0.380.0%0.410.0%0.370.0%
Usd Book Value Change Per Share0.560.0%0.560.0%0.390.0%0.390.0%0.470.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.560.0%0.560.0%0.390.0%0.410.0%0.490.0%
Usd Price Per Share27.15-27.15-0.00-5.43-4.52-
Price to Earnings Ratio48.25-48.25-0.00-9.65-8.04-
Price-to-Total Gains Ratio48.17-48.17-48.17-48.17-
Price to Book Ratio9.64-9.64-0.00-1.93-1.61-
Price-to-Total Gains Ratio48.17-48.17-48.17-48.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share30.10888
Number of shares33
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share0.560.39
Usd Total Gains Per Share0.560.41
Gains per Quarter (33 shares)18.6013.50
Gains per Year (33 shares)74.4054.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10746435144
20149138610298
302232128154152
4029828611205206
5037236014256260
6044643417307314
7052150820358368
8059558223409422
9067065625461476
10074473028512530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%2.00.04.033.3%2.00.04.033.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Mankind Pharma Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--47.76547.7650%33.258+44%32.851+45%39.780+20%
Book Value Per Share--238.677238.6770%190.912+25%160.052+49%145.781+64%
Current Ratio--3.0993.0990%2.323+33%2.446+27%2.364+31%
Debt To Asset Ratio--0.2000.2000%0.213-6%0.247-19%0.252-21%
Debt To Equity Ratio--0.2550.2550%0.278-8%0.343-26%0.353-28%
Dividend Per Share----0%-0%1.818-100%1.615-100%
Eps--47.67947.6790%31.995+49%34.551+38%31.200+53%
Free Cash Flow Per Share--44.12044.1200%23.775+86%14.782+198%13.577+225%
Free Cash Flow To Equity Per Share--44.25144.2510%6.347+597%11.652+280%10.021+342%
Gross Profit Margin--0.6190.6190%0.708-13%0.662-6%0.615+1%
Intrinsic Value_10Y_max--477.777--------
Intrinsic Value_10Y_min--349.569--------
Intrinsic Value_1Y_max--21.966--------
Intrinsic Value_1Y_min--17.059--------
Intrinsic Value_3Y_max--85.746--------
Intrinsic Value_3Y_min--67.123--------
Intrinsic Value_5Y_max--173.333--------
Intrinsic Value_5Y_min--134.195--------
Market Cap1022283230400.000+10%923066594356.250923066594356.2500%-+100%184613318871.250+400%153844432392.708+500%
Net Profit Margin--0.1850.1850%0.147+26%0.179+3%0.169+10%
Operating Margin--0.2350.2350%0.185+27%0.239-1%0.228+3%
Operating Ratio--0.7930.7930%0.815-3%0.772+3%0.779+2%
Pb Ratio10.691+10%9.6409.6400%-+100%1.928+400%1.607+500%
Pe Ratio53.516+10%48.25548.2550%-+100%9.651+400%8.042+500%
Price Per Share2551.600+10%2300.7502300.7500%-+100%460.150+400%383.458+500%
Price To Free Cash Flow Ratio57.833+10%52.14752.1470%-+100%10.429+400%8.691+500%
Price To Total Gains Ratio53.420+10%48.16848.1680%--48.1680%48.1680%
Quick Ratio--3.4963.4960%1.806+94%2.304+52%2.071+69%
Return On Assets--0.1600.1600%0.132+21%0.170-6%0.165-3%
Return On Equity--0.2040.2040%0.172+19%0.235-13%0.230-11%
Total Gains Per Share--47.76547.7650%33.258+44%34.669+38%41.395+15%
Usd Book Value--1129942995.8001129942995.8000%902556925.000+25%756978085.360+49%689454634.233+64%
Usd Book Value Change Per Share--0.5640.5640%0.392+44%0.388+45%0.469+20%
Usd Book Value Per Share--2.8162.8160%2.253+25%1.889+49%1.720+64%
Usd Dividend Per Share----0%-0%0.021-100%0.019-100%
Usd Eps--0.5630.5630%0.378+49%0.408+38%0.368+53%
Usd Free Cash Flow--208872767.600208872767.6000%112397029.600+86%69939577.040+199%64236023.833+225%
Usd Free Cash Flow Per Share--0.5210.5210%0.281+86%0.174+198%0.160+225%
Usd Free Cash Flow To Equity Per Share--0.5220.5220%0.075+597%0.137+280%0.118+342%
Usd Market Cap12062942118.720+10%10892185813.40410892185813.4040%-+100%2178437162.681+400%1815364302.234+500%
Usd Price Per Share30.109+10%27.14927.1490%-+100%5.430+400%4.525+500%
Usd Profit--225721810.600225721810.6000%151259373.800+49%163408354.080+38%147551357.533+53%
Usd Revenue--1219503402.8001219503402.8000%1031656854.600+18%918956843.480+33%863736899.533+41%
Usd Total Gains Per Share--0.5640.5640%0.392+44%0.409+38%0.488+15%
 EOD+4 -4MRQTTM+0 -0YOY+28 -55Y+24 -1110Y+26 -9

3.3 Fundamental Score

Let's check the fundamental score of Mankind Pharma Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1553.516
Price to Book Ratio (EOD)Between0-110.691
Net Profit Margin (MRQ)Greater than00.185
Operating Margin (MRQ)Greater than00.235
Quick Ratio (MRQ)Greater than13.496
Current Ratio (MRQ)Greater than13.099
Debt to Asset Ratio (MRQ)Less than10.200
Debt to Equity Ratio (MRQ)Less than10.255
Return on Equity (MRQ)Greater than0.150.204
Return on Assets (MRQ)Greater than0.050.160
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of Mankind Pharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.526
Ma 20Greater thanMa 502,607.003
Ma 50Greater thanMa 1002,600.094
Ma 100Greater thanMa 2002,403.569
OpenGreater thanClose2,575.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Mankind Pharma Ltd

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

Fundamental data was last updated by Penke on 2024-11-05 22:41:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Mankind Pharma Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Mankind Pharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 18.5% means that ₹0.19 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mankind Pharma Ltd:

  • The MRQ is 18.5%. The company is making a huge profit. +2
  • The TTM is 18.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.5%TTM18.5%0.0%
TTM18.5%YOY14.7%+3.8%
TTM18.5%5Y17.9%+0.6%
5Y17.9%10Y16.9%+1.0%
4.3.1.2. Return on Assets

Shows how efficient Mankind Pharma Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mankind Pharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.0% Return on Assets means that Mankind Pharma Ltd generated ₹0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mankind Pharma Ltd:

  • The MRQ is 16.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 16.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.0%TTM16.0%0.0%
TTM16.0%YOY13.2%+2.8%
TTM16.0%5Y17.0%-1.0%
5Y17.0%10Y16.5%+0.5%
4.3.1.3. Return on Equity

Shows how efficient Mankind Pharma Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mankind Pharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 20.4% Return on Equity means Mankind Pharma Ltd generated ₹0.20 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mankind Pharma Ltd:

  • The MRQ is 20.4%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 20.4%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.4%TTM20.4%0.0%
TTM20.4%YOY17.2%+3.2%
TTM20.4%5Y23.5%-3.0%
5Y23.5%10Y23.0%+0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Mankind Pharma Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Mankind Pharma Ltd is operating .

  • Measures how much profit Mankind Pharma Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mankind Pharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 23.5% means the company generated ₹0.24  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mankind Pharma Ltd:

  • The MRQ is 23.5%. The company is operating efficient. +1
  • The TTM is 23.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ23.5%TTM23.5%0.0%
TTM23.5%YOY18.5%+5.0%
TTM23.5%5Y23.9%-0.3%
5Y23.9%10Y22.8%+1.1%
4.3.2.2. Operating Ratio

Measures how efficient Mankind Pharma Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are ₹0.79 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Mankind Pharma Ltd:

  • The MRQ is 0.793. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.793. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.793TTM0.7930.000
TTM0.793YOY0.815-0.022
TTM0.7935Y0.772+0.022
5Y0.77210Y0.779-0.008
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Mankind Pharma Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Mankind Pharma Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.10 means the company has ₹3.10 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Mankind Pharma Ltd:

  • The MRQ is 3.099. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.099. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.099TTM3.0990.000
TTM3.099YOY2.323+0.776
TTM3.0995Y2.446+0.653
5Y2.44610Y2.364+0.082
4.4.3.2. Quick Ratio

Measures if Mankind Pharma Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mankind Pharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.50 means the company can pay off ₹3.50 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mankind Pharma Ltd:

  • The MRQ is 3.496. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.496. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.496TTM3.4960.000
TTM3.496YOY1.806+1.690
TTM3.4965Y2.304+1.192
5Y2.30410Y2.071+0.233
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Mankind Pharma Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Mankind Pharma Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mankind Pharma Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.20 means that Mankind Pharma Ltd assets are financed with 20.0% credit (debt) and the remaining percentage (100% - 20.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mankind Pharma Ltd:

  • The MRQ is 0.200. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.200. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.200TTM0.2000.000
TTM0.200YOY0.213-0.013
TTM0.2005Y0.247-0.047
5Y0.24710Y0.252-0.005
4.5.4.2. Debt to Equity Ratio

Measures if Mankind Pharma Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mankind Pharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 25.5% means that company has ₹0.25 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mankind Pharma Ltd:

  • The MRQ is 0.255. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.255. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.2550.000
TTM0.255YOY0.278-0.023
TTM0.2555Y0.343-0.088
5Y0.34310Y0.353-0.010
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Mankind Pharma Ltd generates.

  • Above 15 is considered overpriced but always compare Mankind Pharma Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 48.25 means the investor is paying ₹48.25 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mankind Pharma Ltd:

  • The EOD is 53.516. Based on the earnings, the company is expensive. -2
  • The MRQ is 48.255. Based on the earnings, the company is overpriced. -1
  • The TTM is 48.255. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD53.516MRQ48.255+5.261
MRQ48.255TTM48.2550.000
TTM48.255YOY-+48.255
TTM48.2555Y9.651+38.604
5Y9.65110Y8.042+1.608
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Mankind Pharma Ltd:

  • The EOD is 57.833. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 52.147. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 52.147. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD57.833MRQ52.147+5.686
MRQ52.147TTM52.1470.000
TTM52.147YOY-+52.147
TTM52.1475Y10.429+41.718
5Y10.42910Y8.691+1.738
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Mankind Pharma Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 9.64 means the investor is paying ₹9.64 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Mankind Pharma Ltd:

  • The EOD is 10.691. Based on the equity, the company is expensive. -2
  • The MRQ is 9.640. Based on the equity, the company is overpriced. -1
  • The TTM is 9.640. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.691MRQ9.640+1.051
MRQ9.640TTM9.6400.000
TTM9.640YOY-+9.640
TTM9.6405Y1.928+7.712
5Y1.92810Y1.607+0.321
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-03-312021-03-312022-03-312023-03-312024-03-31
Accumulated Other Comprehensive Income  -6,623,251-13,569-6,636,82015,480-6,621,34029,786-6,591,55499,821,84793,230,293



6.2. Latest Balance Sheet

Balance Sheet of 2024-03-31. All numbers in thousands.

Summary
Total Assets119,632,547
Total Liabilities23,874,666
Total Stockholder Equity93,630,881
 As reported
Total Liabilities 23,874,666
Total Stockholder Equity+ 93,630,881
Total Assets = 119,632,547

Assets

Total Assets119,632,547
Total Current Assets65,682,262
Long-term Assets53,950,285
Total Current Assets
Cash And Cash Equivalents 3,820,075
Short-term Investments 30,872,355
Net Receivables 8,538,452
Inventory 15,534,612
Other Current Assets 6,916,768
Total Current Assets  (as reported)65,682,262
Total Current Assets  (calculated)65,682,262
+/-0
Long-term Assets
Property Plant Equipment 31,386,868
Goodwill 200,225
Intangible Assets 16,630,389
Long-term Assets  (as reported)53,950,285
Long-term Assets  (calculated)48,217,482
+/- 5,732,803

Liabilities & Shareholders' Equity

Total Current Liabilities21,197,298
Long-term Liabilities2,677,368
Total Stockholder Equity93,630,881
Total Current Liabilities
Short-term Debt 1,745,909
Accounts payable 11,029,908
Other Current Liabilities 1,709,131
Total Current Liabilities  (as reported)21,197,298
Total Current Liabilities  (calculated)14,484,948
+/- 6,712,350
Long-term Liabilities
Long-term Liabilities  (as reported)2,677,368
Long-term Liabilities  (calculated)0
+/- 2,677,368
Total Stockholder Equity
Common Stock400,588
Retained Earnings 99,188,365
Accumulated Other Comprehensive Income 93,230,293
Other Stockholders Equity -99,188,365
Total Stockholder Equity (as reported)93,630,881
Total Stockholder Equity (calculated)93,630,881
+/-0
Other
Cash and Short Term Investments 34,692,430
Common Stock Shares Outstanding 401,202
Current Deferred Revenue6,712,350
Liabilities and Stockholders Equity 119,632,547
Net Debt -1,748,351
Net Working Capital 44,484,964
Short Long Term Debt Total 2,071,724



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-31
> Total Assets 
41,124,238
50,732,850
63,726,320
91,477,400
97,154,491
119,632,547
119,632,54797,154,49191,477,40063,726,32050,732,85041,124,238
   > Total Current Assets 
19,981,150
28,222,150
39,066,370
44,068,190
43,278,720
65,682,262
65,682,26243,278,72044,068,19039,066,37028,222,15019,981,150
       Cash And Cash Equivalents 
1,163,903
2,260,760
1,671,820
3,025,340
3,048,207
3,820,075
3,820,0753,048,2073,025,3401,671,8202,260,7601,163,903
       Short-term Investments 
246,211
8,582,680
18,373,000
9,767,750
12,238,520
30,872,355
30,872,35512,238,5209,767,75018,373,0008,582,680246,211
       Net Receivables 
2,202,188
6,260,823
4,242,050
4,267,190
6,123,627
8,538,452
8,538,4526,123,6274,267,1904,242,0506,260,8232,202,188
       Inventory 
8,209,853
8,991,350
11,835,390
17,602,390
15,288,533
15,534,612
15,534,61215,288,53317,602,39011,835,3908,991,3508,209,853
       Other Current Assets 
8,158,995
1,902,637
2,658,260
8,718,440
6,579,833
6,916,768
6,916,7686,579,8338,718,4402,658,2601,902,6378,158,995
   > Long-term Assets 
21,143,088
22,510,700
24,659,950
47,409,210
53,875,771
53,950,285
53,950,28553,875,77147,409,21024,659,95022,510,70021,143,088
       Property Plant Equipment 
16,789,367
18,646,030
19,916,880
23,895,930
30,757,951
31,386,868
31,386,86830,757,95123,895,93019,916,88018,646,03016,789,367
       Goodwill 
204,456
204,420
204,420
204,420
200,225
200,225
200,225200,225204,420204,420204,420204,456
       Intangible Assets 
279,471
259,480
187,630
18,742,040
17,584,169
16,630,389
16,630,38917,584,16918,742,040187,630259,480279,471
       Long-term Assets Other 
1,713,201
9,860,130
20,136,550
11,537,730
1,311,199
32,408,154
32,408,1541,311,19911,537,73020,136,5509,860,1301,713,201
> Total Liabilities 
11,307,511
14,017,150
15,097,430
28,314,320
20,666,616
23,874,666
23,874,66620,666,61628,314,32015,097,43014,017,15011,307,511
   > Total Current Liabilities 
10,240,618
12,585,890
13,533,980
26,234,690
18,631,362
21,197,298
21,197,29818,631,36226,234,69013,533,98012,585,89010,240,618
       Short-term Debt 
2,451,229
777,170
1,784,780
8,208,910
1,420,464
1,745,909
1,745,9091,420,4648,208,9101,784,780777,1702,451,229
       Short Long Term Debt 
0
765,770
1,768,560
8,188,340
0
0
008,188,3401,768,560765,7700
       Accounts payable 
5,619,690
7,451,140
6,669,680
10,763,770
10,081,769
11,029,908
11,029,90810,081,76910,763,7706,669,6807,451,1405,619,690
       Other Current Liabilities 
2,169,699
551,460
851,770
2,057,410
6,865,440
1,709,131
1,709,1316,865,4402,057,410851,770551,4602,169,699
   > Long-term Liabilities 
1,066,893
1,431,260
1,563,450
2,079,630
2,035,254
2,677,368
2,677,3682,035,2542,079,6301,563,4501,431,2601,066,893
> Total Stockholder Equity
28,230,501
34,853,090
47,220,020
61,552,290
74,352,228
93,630,881
93,630,88174,352,22861,552,29047,220,02034,853,09028,230,501
   Common Stock
400,588
400,590
400,590
400,590
400,588
400,588
400,588400,588400,590400,590400,590400,588
   Retained Earnings 
36,453,637
40,654,590
53,035,080
67,351,870
80,122,020
99,188,365
99,188,36580,122,02067,351,87053,035,08040,654,59036,453,637
   Accumulated Other Comprehensive Income 
-9,044,898
-6,623,251
-6,636,820
-6,621,340
-6,591,554
93,230,293
93,230,293-6,591,554-6,621,340-6,636,820-6,623,251-9,044,898
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
421,174
-6,202,090
-6,215,650
-6,200,170
421,174
-99,188,365
-99,188,365421,174-6,200,170-6,215,650-6,202,090421,174



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-03-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue103,347,746
Cost of Revenue-32,096,959
Gross Profit71,250,78771,250,787
 
Operating Income (+$)
Gross Profit71,250,787
Operating Expense-49,882,603
Operating Income24,328,89821,368,184
 
Operating Expense (+$)
Research Development2,226,048
Selling General Administrative2,607,902
Selling And Marketing Expenses7,290,325
Operating Expense49,882,60312,124,275
 
Net Interest Income (+$)
Interest Income0
Interest Expense-335,316
Other Finance Cost-335,316
Net Interest Income0
 
Pretax Income (+$)
Operating Income24,328,898
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)23,993,58224,664,214
EBIT - interestExpense = 23,994,129
23,704,832
19,464,283
Interest Expense335,316
Earnings Before Interest and Taxes (EBIT)24,329,44524,328,898
Earnings Before Interest and Taxes (EBITDA)28,311,435
 
After tax Income (+$)
Income Before Tax23,993,582
Tax Provision-0
Net Income From Continuing Ops023,993,582
Net Income19,128,967
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses81,979,562
Total Other Income/Expenses Net-335,3160
 

Technical Analysis of Mankind Pharma Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mankind Pharma Ltd. The general trend of Mankind Pharma Ltd is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mankind Pharma Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Mankind Pharma Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2,874.

The bearish price targets are: 2,506 > 2,405 > 2,378.

Tweet this
Mankind Pharma Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Mankind Pharma Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Mankind Pharma Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Mankind Pharma Ltd. The current macd is -6.39730599.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Mankind Pharma Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Mankind Pharma Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Mankind Pharma Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Mankind Pharma Ltd Daily Moving Average Convergence/Divergence (MACD) ChartMankind Pharma Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Mankind Pharma Ltd. The current adx is 19.18.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Mankind Pharma Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Mankind Pharma Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Mankind Pharma Ltd. The current sar is 2,839.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Mankind Pharma Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Mankind Pharma Ltd. The current rsi is 44.53. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Mankind Pharma Ltd Daily Relative Strength Index (RSI) ChartMankind Pharma Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Mankind Pharma Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Mankind Pharma Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Mankind Pharma Ltd Daily Stochastic Oscillator ChartMankind Pharma Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Mankind Pharma Ltd. The current cci is -51.26316475.

Mankind Pharma Ltd Daily Commodity Channel Index (CCI) ChartMankind Pharma Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Mankind Pharma Ltd. The current cmo is -20.25879869.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Mankind Pharma Ltd Daily Chande Momentum Oscillator (CMO) ChartMankind Pharma Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Mankind Pharma Ltd. The current willr is -87.62060063.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Mankind Pharma Ltd Daily Williams %R ChartMankind Pharma Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Mankind Pharma Ltd.

Mankind Pharma Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Mankind Pharma Ltd. The current atr is 88.07.

Mankind Pharma Ltd Daily Average True Range (ATR) ChartMankind Pharma Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Mankind Pharma Ltd. The current obv is 48,362,231.

Mankind Pharma Ltd Daily On-Balance Volume (OBV) ChartMankind Pharma Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Mankind Pharma Ltd. The current mfi is 59.75.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Mankind Pharma Ltd Daily Money Flow Index (MFI) ChartMankind Pharma Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Mankind Pharma Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

Mankind Pharma Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Mankind Pharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.526
Ma 20Greater thanMa 502,607.003
Ma 50Greater thanMa 1002,600.094
Ma 100Greater thanMa 2002,403.569
OpenGreater thanClose2,575.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Mankind Pharma Ltd with someone you think should read this too:
  • Are you bullish or bearish on Mankind Pharma Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mankind Pharma Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Mankind Pharma Ltd

I send you an email if I find something interesting about Mankind Pharma Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Mankind Pharma Ltd.

Receive notifications about Mankind Pharma Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.